1910 Genetics Receives Investment From Accenture Ventures
Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a. October 31, 2024 at 10:55 am edt. Accenture has invested, through accenture ventures, in 1910 genetics, a biotech company advancing small and large molecule drug. Accenture ventures, the venture capital arm of accenture, has invested in 1910 genetics, a biotechnology company focused on drug discovery using a multimodal artificial. Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a biotechnology company advancing small and large molecule drug.
Key figures from both companies will join advisory boards, and 1910 will join accenture ventures’ project spotlight for emerging technologies. Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a biotechnology.